Cardiology - Case Reports
August 3, 2020
Vol. 90 No. 3 (2020)
A case of vasospastic angina. Vasospasm physiopathology: a new therapeutic role for ranolazine?
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
1070
Views
652
Downloads
Authors
We report the case of a 40-year-old man, transferred from another hospital to our ICU because of acute coronary syndrome. Coronarography did not show coronary stenosis. Twenty-four hours monitoring EKG allowed diagnosis of Prinzmetal angina and appropriate therapy was administered. Six months after discharge due recurrence of symptoms, ranolazine was added to therapy. After one year the patient is symptoms free.
Altmetrics
Downloads
Download data is not yet available.
Citations
How to Cite
“A Case of Vasospastic Angina. Vasospasm Physiopathology: A New Therapeutic Role for Ranolazine?”. 2020. Monaldi Archives for Chest Disease 90 (3). https://doi.org/10.4081/monaldi.2020.1295.